studied 117 human epidermal growth factor receptor 2 (HER2)-negative patients with advanced gastric cancer who underwent treatments such as chemotherapy alone, immunotherapy alone, and immune-combination chemotherapy regimens. The gene discussed is ERBB2; the disease is gastric cancer.